PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.18%
Negative revenue growth while MCHP stands at 10.82%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-54.96%
Negative gross profit growth while MCHP is at 15.09%. Joel Greenblatt would examine cost competitiveness or demand decline.
23.89%
EBIT growth below 50% of MCHP's 140.04%. Michael Burry would suspect deeper competitive or cost structure issues.
23.89%
Operating income growth under 50% of MCHP's 132.00%. Michael Burry would be concerned about deeper cost or sales issues.
5.19%
Net income growth under 50% of MCHP's 87.97%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.97%
Share count expansion well above MCHP's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.97%
Diluted share count expanding well above MCHP's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
-10.10%
Dividend reduction while MCHP stands at 10.17%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-70.45%
Negative OCF growth while MCHP is at 33.85%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-120.49%
Negative FCF growth while MCHP is at 34.43%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
36.26%
10Y revenue/share CAGR at 50-75% of MCHP's 51.09%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
10.62%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
9.60%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.27%
Positive 3Y OCF/share CAGR while MCHP is negative. John Neff might see a big short-term edge in operational efficiency.
616.08%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-18.38%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
456.75%
Positive short-term CAGR while MCHP is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.07%
Negative 3Y equity/share growth while MCHP is at 17.81%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
33.94%
Below 50% of MCHP's 175.02%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-18.09%
Negative near-term dividend growth while MCHP invests at 81.65%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
3.28%
AR growth is negative/stable vs. MCHP's 10.99%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
4.50%
We show growth while MCHP is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
7.75%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.80%
Positive BV/share change while MCHP is negative. John Neff sees a clear edge over a competitor losing equity.
-2.91%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
0.30%
SG&A declining or stable vs. MCHP's 4.80%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.